Georgia vs Oman: Number of clinical trials
Georgia
5 trials
in 2024
Oman
5 trials
in 2024
Georgia rank
85th
Oman rank
85th
Number of clinical trials over time
- Georgia
- Oman
How they compare
Georgia currently reports 5 trials against 5 trials in Oman, a difference of 0 trials.
The two have swapped places 2 times across 6 shared years of data; in 2013 it was Oman ahead.
Georgia ranks 85th and Oman ranks 85th of 153 countries.
Georgia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.5 trials | 2.5 trials | 3 trials | Georgia |
| 2020s | 5.5 trials | 3.5 trials | 2 trials | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Georgia or Oman?
- Georgia, at 5 trials against 5 trials in Oman as of 2024.
- What is the difference in number of clinical trials between Georgia and Oman?
- 0 trials, with Georgia ahead.
- How many years of comparable data are there for Georgia and Oman?
- 6 years are reported by both, from 2013 to 2024.
- How do Georgia and Oman rank globally for number of clinical trials?
- Georgia ranks 85th and Oman ranks 85th of 153 countries.
- Where does this data come from?
- ClinicalTrials.gov (2025) – with major processing by Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Annual number of completed clinical trials registered in the ClinicalTrials.gov database for each country. Registration in the ClinicalTrials database is mandatory for trials in the United States, but voluntary for other countries.